-
Cy3 TSA Fluorescence System Kit for Sparse Signals
2026-09-03
Learn how the Cy3 TSA Fluorescence System Kit can improve detection of sparse olfactory receptor signals while preserving spatial information. This article connects tyramide chemistry with the TRIM66 mechanism and practical assay design.
-
Bay 11-7821: From NF-κB Mechanism to Translation
2026-09-03
Bay 11-7821, also known as BAY 11-7082, is a versatile research tool for connecting IKK/NF-κB signaling with apoptosis, inflammasome biology, and translational models of inflammation and cancer. This article places the compound alongside emerging lactate-HMGB1 biology in sepsis and outlines a disciplined strategy for interpreting pharmacology across macrophage, endothelial, lymphoma, and tumor systems.
-
1-methyl Adenosine: Applied Quantification Workflows
2026-09-02
Build a practical 1-methyl Adenosine workflow that connects cell perturbation, RNA modification research, and targeted UHPLC–MS/MS. The approach emphasizes isomer resolution, matrix control, and biomarker-ready validation rather than relying on a single endpoint.
-
PEI-Modified Laminarin Nanoparticles as Vaccine Adjuvants
2026-09-02
The reference study developed polyethyleneimine-modified laminarin nanoparticles that combine a cationic polysaccharide carrier with ovalbumin to improve antigen uptake, dendritic-cell activation, lysosomal escape, and cross-presentation. Compared with aluminum adjuvant, the formulation produced stronger OVA-specific humoral and cellular immune responses, while also illustrating how polysaccharide functionalization can guide nanovaccine performance.
-
(+)-Bicuculline: Protocol and QC Guide
2026-09-01
This guide explains how to formulate and control (+)-Bicuculline, a GABAA receptor antagonist used to investigate inhibitory neurotransmission and related synaptic signaling. It is a research-use neuroscience tool only; formulation, storage, and interpretation should not be transferred to diagnostic, therapeutic, or clinical use.
-
OTUD3–SLC7A11 Axis in Sunitinib Resistance
2026-09-01
A 2025 Cancer Letters study identifies OTUD3-mediated deubiquitination of SLC7A11 as a mechanism that protects clear cell renal cell carcinoma from sunitinib-induced ferroptosis. The work links post-translational control of cystine transport to glutathione preservation, reduced lipid peroxidation, and treatment resistance, suggesting that OTUD3 inhibition could improve sunitinib response.
-
Hexamethonium Bromide for Autonomic Research
2026-08-31
Hexamethonium Bromide helps separate autonomic ganglia activity from vascular and cardiac effects in conscious cardiovascular models. This workflow translates sex-dependent angiotensin II hypertension findings into practical telemetry, solution-handling, control, and troubleshooting choices.
-
Carbapenemase Transmission in CREC Across Guangdong
2026-08-31
This study integrates carbapenemase gene localization, conjugative transfer, mobile genetic elements, strain relatedness, and hospital epidemiology in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. Its central finding is that blaNDM-1 was common and frequently plasmid-associated, while the high transferability of carbapenemase-encoding genes underscores the need for mobility-aware surveillance and infection-control strategies.
-
ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors
2026-08-30
The reference study used a drug screen to identify receptor tyrosine kinase and PDGFR inhibitors that preferentially affect ATRX-deficient high-grade glioma cells. Its combination experiments further showed that pairing these inhibitors with temozolomide produced pronounced toxicity, supporting ATRX status as a potentially useful biomarker for treatment-response interpretation.
-
Rucaparib and Spliceosome-Linked DNA Repair
2026-08-29
Rucaparib and AG-014699 provide a mechanistically rich platform for studying PARP1 inhibition, persistent DNA damage, and cancer-cell repair states. This article connects prostate cancer radiosensitization with emerging SmD2-dependent spliceosome biology in hepatocellular carcinoma to improve assay interpretation.
-
NET-DNA–CCDC25 Control of ILC3 Repair in Colitis
2026-08-28
This 2026 FASEB Journal study identifies a mechanistic pathway linking neutrophil extracellular trap DNA to impaired intestinal epithelial repair in ulcerative colitis. Its findings implicate CCDC25-dependent suppression of ILC3-derived IL-22, connecting extracellular DNA accumulation with reduced mucus, tight-junction integrity, and epithelial regeneration.
-
Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-08-28
The 2024 bioRxiv preprint shows that selected kinase inhibitors can do more than occupy the p38α active site: they can shift its activation-loop conformation to accelerate WIP1-catalyzed dephosphorylation. Its biochemical, kinetic, and X-ray structural evidence suggests a route to kinase inhibitors that combine immediate activity blockade with phosphatase-assisted signal shutdown, while leaving compound-specific translation to be tested.
-
Pam3CSK4: TLR1/2 Assays and Reflex Inflammation
2026-08-27
Build cleaner innate-immune experiments with Pam3CSK4, a defined TLR1/2 agonist for macrophage, platelet, and allergic inflammation workflows. Pair receptor-level stimulation with the neural controls highlighted by recent TRPV1 research to distinguish direct immune signaling from somato-autonomic regulation.
-
Berberine Hydrochloride: Gut–Bone Research Workflows
2026-08-27
Build reproducible metabolic, microbiome, organoid, and osteoimmune assays with Berberine hydrochloride rather than treating it as a single-endpoint reagent. This workflow translates tuft-cell and gut–bone findings into practical controls, solvent strategies, and troubleshooting decisions while preserving clear boundaries between preclinical evidence and therapeutic claims.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-26
The Hoechst 33342/PI Double Staining Kit provides a two-color fluorescence workflow for distinguishing nuclear chromatin changes from loss of cell membrane integrity in cultured cells. It is intended for research use only; it should not be used as a standalone diagnostic test or as definitive proof of a specific cell-death mechanism.